CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Baxter International Inc   (BAX)
Other Ticker:  
 

Cumulative Baxter International Inc 's Long Term Debt to Equity for Trailing Twelve Months Period

BAX's Long Term Debt to Equity for Trailing Twelve Months Period and Long Term Debt, Equity growth


Select the Comparisons : Select the Ratio:

BAX Long Term Debt to Equity for Trailing Twelve Months Period

 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Equity Growth 36.89 % 38.61 % 43.65 % 46.37 % -36.75 %
Y / Y Long Term Debt Growth -27.05 % -27.4 % - -12.91 % -
Long Term Debt to Equity for Trailing Twelve Months Period 1.43 1.66 1.94 1.7 1.98
Total Ranking # 1907 # 2059 # 2184 # 2526 # 2668
Seq. Equity Growth -6.4 % -2.75 % 3.7 % 45.02 % -5.22 %
Seq. Long Term Debt Growth -5.91 % -0.34 % -20.88 % -1.67 % -6.36 %

BAX Segments >> Back to BAX Financial Strength Comparisons >> Compare BAX Total Debt to Equity Ratio to its Competitors

Long Term Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2024
On the trailing twelve months basis Due to long-term debt repayement of -5.91% Baxter International Inc decreased Long Term Debt to Equity for Trailing Twelve Months Period in the II. Quarter to 1.43, above Baxter International Inc 's average Long Term Debt to Equity for Trailing Twelve Months Period.
Long Term Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 78 other companies have achieved lower Long Term Debt to Equity for Trailing Twelve Months Period than Baxter International Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Long Term Debt to Equity Ratio?
What is BAX selling?
Long Term Debt to Equity BAX in the most recent quarter
Long Term Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 79
Sector # 225
S&P 500 # 1878


Long Term Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
1.98 0.7 0.11
(Jun 30 2023)   (Sep 30 2019)




Companies with similar average Long Term Debt to Equity for Trailing Twelve Months Period for 12 months ending Jun 30 2024, within Medical Equipment & Supplies Industry Long Term Debt to Equity for Trailing Twelve Months Period
Transmedics Group Inc   3.72 
Neuropace Inc   3.69 
Biolase Inc   3.34 
Accuray Incorporated  3.26 
3m Company  2.71 
Owens and Minor inc   2.33 
Irhythm Technologies Inc   2.15 
Acutus Medical Inc   1.91 
Insulet Corporation  1.85 
Tela Bio Inc   1.85 
Motus Gi Holdings Inc   1.84 
Baxter International Inc   1.68 
Bioventus Inc   1.67 
Novocure Limited  1.54 
Neuronetics Inc   1.37 
P3 Health Partners Inc   1.28 
Minerva Surgical Inc   1.26 
Zynex inc   1.23 
Conmed Corporation  1.17 
Tandem Diabetes Care Inc   1.16 
Cerus Corporation  1.16 
Strata Skin Sciences Inc   1.16 
Artivion Inc   1.08 
Dexcom Inc   1.08 
Integra Lifesciences Holdings Corp  0.97 
Haemonetics Corporation  0.97 
Sonendo Inc   0.82 
Uphealth Inc   0.77 
Icu Medical Inc  0.76 
Medinotec Inc   0.76 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com